Current Edition

Patient Recruitment: The Most Recognised Silent Driver of Clinical Development Costs.

Patient recruitment challenges the drug development process for a number of reasons. Elio Evangelista at Cutting Edge Information discusses why the increased demand for clinical trial patients, combined with the relatively flat growth in clinical investigators and study sites, places the pharmaceutical industry in a predicament.
[prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/04/Patient-Recruitment-The-Most-Recognized-Silent-Driver-of-Clinical-Development-Costs.pdf” type=”pdf”]Patient Recruitment The Most Recognized Silent Driver of Clinical Development Costs[/prettyfilelink]
http://ipimediaworld.com/wp-content/uploads/2013/04/Patient-Recruitment-The-Most-Recognized-Silent-Driver-of-Clinical-Development-Costs.pdf